Small molecule therapy for alzheimer's disease
Ended Project Grant Awarded Last action
- Award ID
- R44AG050336
- Recipient
-
Recombinant Technologies LLC UEI LC6JYTFEJ5N1
- Awarding agency
-
National Institute on Aging
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,696,216
Award facts
- Assistance listing
- 93.866 Aging Research
- Completion date
- Originally
- Place of performance
- Cheshire, CT 06410, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $519,209 | |
| Amendment | $138,589 | |
| Amendment | $519,209 | |
| Original award | $519,209 |
Quick answers
Who received award R44AG050336?
R44AG050336 was awarded to Recombinant Technologies LLC by National Institute on Aging (National Institutes of Health) on May 15, 2016.
How much is award R44AG050336 worth?
$1,696,216 has been obligated on R44AG050336.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award